ripekg:author/RIPEAU54170F81C15D3113Shahrzad Ommi |
rdf:type |
node1 |
ripekg:author/RIPEAU54170F81C15D3113Shahrzad Ommi |
rdf:type |
rdfs:Resource |
ripekg:author/RIPEAU54170F81C15D3113Shahrzad Ommi |
rdf:type |
owl:Thing |
ripekg:author/RIPEAU54170F81C15D3113Shahrzad Ommi |
rdf:type |
prov:Person |
ripekg:author/RIPEAU54170F81C15D3113Shahrzad Ommi |
rdf:type |
foaf:Person |
ripekg:author/RIPEAU54170F81C15D3113Shahrzad Ommi |
rdf:type |
ripe:AuthorAuthor |
ripekg:author/RIPEAU54170F81C15D3113Shahrzad Ommi |
owl:sameAs |
https://semopenalex.org/author/A5036471291 |
ripekg:author/RIPEAU54170F81C15D3113Shahrzad Ommi |
http://www.w3.org/ns/org#memberOf |
ripekg:organization/RIPEOEF54593BB5D8B8ABDepartment of Dietetics and Nutrition |
ripekg:author/RIPEAU54170F81C15D3113Shahrzad Ommi |
foaf:familyName |
Ommi |
ripekg:author/RIPEAU54170F81C15D3113Shahrzad Ommi |
foaf:givenName |
Shahrzad |
ripekg:author/RIPEAU54170F81C15D3113Shahrzad Ommi |
foaf:name |
Shahrzad Ommi |
ripekg:work/10.1002%2Fptr.6406Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial |
dcterms:creator |
ripekg:author/RIPEAU54170F81C15D3113Shahrzad Ommi |